Cited by 149Gut microbiota and healthLiver Diseases and ImmunityInflammatory Bowel Disease

The features of mucosa‐associated microbiota in primary sclerosing cholangitis

Open access
Torres, J., Bao, X., Goel, A., Colombel, J.‐F., Pekow, J., Jabri, B., Williams, K.M., Castillo, A. +6 more·2016·Alimentary Pharmacology & Therapeutics

Abstract

Summary: Background: Little is known about the role of the microbiome in primary sclerosing cholangitis. Aim: To explore the mucosa‐associated microbiota in primary sclerosing cholangitis (PSC) patients across different locations in the gut, and to compare it with inflammatory bowel disease (IBD)‐only patients and healthy controls. Methods: Biopsies from the terminal ileum, right colon, and left colon were collected from patients and healthy controls undergoing colonoscopy. Microbiota profiling using bacterial 16S rRNA sequencing was performed on all biopsies. Results: Forty‐four patients were recruited: 20 with PSC (19 with PSC‐IBD and one with PSC‐only), 15 with IBD‐only and nine healthy controls. The overall microbiome profile was similar throughout different locations in the gut. No differences in the global microbiome profile were found. However, we observed significant PSC‐associated enrichment in Barnesiellaceae at the family level, and in Blautia and an unidentified Barnesiellaceae at the genus level. At the operational taxa unit level, most shifts in PSC were observed in Clostridiales and Bacteroidales orders, with approximately 86% of shifts occurring within the former order. Conclusions: The overall microbiota profile was similar across multiple locations in the gut from the same individual regardless of disease status. In this study, the mucosa associated‐microbiota of patients with primary sclerosing cholangitis was characterised by enrichment of Blautia and Barnesiellaceae and by major shifts in operational taxa units within Clostridiales order.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.13552

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent studies support an association between changes in the microbiome and the progression of cholestatic liver disease in patients.

    “Recent studies have further supported the association between changes in the microbiome and the progression of cholestatic liver disease in patients9–14.”
  • Changes at genera level in cholestatic patients differ among studies and include enrichment in Veillonella, Akkermansia, Ruminococcaceae (undefined genus) and Clostridium and decrease in Prevotella.

    “The changes described at genera level differ among studies9–12 and include the enrichment in Veillonella, Akkermansia, Ruminococcaceae (undefined genus) and Clostridium9 and the decrease in Prevotella10, overall supporting the association between changes in the microbiome and cholestatic disease.”
  • Recent studies described that cholestatic patients with PSC have an overall less diverse microbiome composition.

    “Recent studies described that cholestatic patients with PSC have an overall less diverse microbiome composition.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 49 · Cited by 149

Authors
Torres, J., Bao, X., Goel, A., Colombel, J. ‐., Pekow, J., Jabri, B., Williams, K. M., Castillo, A., Odin, J. A., Meckel, K., Fasihuddin, F., Peter, I., Itzkowitz, S., & Hu, J.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • University of Chicago (US)
  • Section of Gastroenterology, Hepatology, and Nutrition University of Chicago Chicago IL USA
Corresponding author
Hu, J.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2016-02-09
Volume
43
Issue
7
Pages
790-801
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2259743485
Cited by
149
References
49
Citations by year
2026: 4 · 2025: 7 · 2024: 18 · 2023: 11 · 2022: 16 · 2021: 14 · 2020: 13 · 2019: 25 · 2018: 13 · 2017: 20 · 2016: 7
FWCI
11.26
Type
journal article
Language
en
Open access
Locations
  • Alimentary Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (1K01DK094986‐01)
  • Chemotherapy Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
Keywords
primary sclerosing cholangitis, gut microbiota, mucosa-associated microbiota, inflammatory bowel disease, Blautia, Clostridiales, Bacteroidales, terminal ileum, colon
MeSH terms
Adult, Aged, Colitis, Ulcerative, Colonoscopy, Female, Humans, Intestinal Mucosa, Male, Middle Aged, RNA, Ribosomal, 16S, Cholangitis, Sclerosing, Inflammatory Bowel Diseases, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review